EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gene silencing of endothelial von Willebrand factor reduces the susceptibility of human endothelial cells to SARS‐CoV ‐2 infection

Giulia Furini, Alessandro De Carli, Rossella Fonnesu, Pietro Giorgio Spezia, Francesca Scebba, Mauro Pistello, Michele Lai, Vincenzo Lionetti iD

The FEBS Journal · 2023

DOI: 10.1111/febs.16808 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FEBS Journal, 2023. Verfasst von Giulia Furini und 7 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Translational Critical Care Medicine, Laboratory of Basic and Applied Medical Sciences, Interdisciplinary Research Center "Health Science", S…. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione Pisa, Scuola Superiore Sant'Anna, Università di Pisa.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mechanisms underlying vascular endothelial susceptibility to infection by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) are not fully understood. Emerging evidence indicates that patients lacking von Willebrand factor (vWF), an endothelial hallmark, are less severely affected by SARS‐CoV‐2 infection, yet the precise role of endothelial vWF in modulating coronavirus entry into endothelial cells is unknown. In the present study, we demonstrated that effective gene silencing by short interfering RNA (siRNA) for vWF expression in resting human umbilical vein endothelial cells (HUVECs) significantly reduced by 56% the cellular levels of SARS‐CoV‐2 genomic RNA. Similar reduction in intracellular SARS‐CoV‐2 genomic RNA levels was observed in non‐activated HUVECs treated with siRNA targeting angiotensin‐converting enzyme 2 (ACE2), the cellular gateway to coronavirus. By integrating quantitative information from real‐time PCR and high‐resolution confocal imaging, we demonstrated that ACE2 gene expression and its plasma membrane localization in HUVECs were both markedly reduced after treatment with siRNA anti‐vWF or anti‐ACE2. Conversely, siRNA anti‐ACE2 did not reduce endothelial vWF gene expression and protein levels. Finally, SARS‐CoV‐2 infection of viable HUVECs was enhanced by overexpression of vWF, which increased ACE2 levels. Of note, we found a similar increase in interferon‐β mRNA levels following transfection with untargeted, anti‐vWF or anti‐ACE2 siRNA and pcDNA3.1‐WT‐VWF. We envision that siRNA targeting endothelial vWF will protect against productive endothelial infection by SARS‐CoV‐2 through downregulation of ACE2 expression and might serve as a novel tool to induce disease resistance by modulating the regulatory role of vWF on ACE2 expression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansSARS-CoV-2von Willebrand FactorEndothelial CellsPeptidyl-Dipeptidase ARNA, Small InterferingGene Silencing

Stichwörter der Autor:innen

ACE2COVID-19SARS-CoV-2endothelial cellsvWF

Substanzen

von Willebrand FactorPeptidyl-Dipeptidase ARNA, Small Interfering

Autor:innen und Institutionen

  • Unit of Translational Critical Care Medicine, Laboratory of Basic and Applied Medical Sciences, Interdisciplinary Research Center "Health Science", Scuola Superiore Sant'Anna, Pisa, Italy.
  • UOSVD Anesthesia and Resuscitation, Fondazione Toscana "G. Monasterio", Pisa, Italy.
  • Virology Section, Department of Translational Research and New Technologies in Medicine and Surgery, Retrovirus Center, University of Pisa, Italy.
  • BioMedicine Laboratory, Interdisciplinary Research Center "Health Science", Scuola Superiore Sant'Anna, Pisa, Italy.
  • Virology Unit, Pisa University Hospital, Italy.
  • CISUP - Centre for Instrumentation Sharing - University of Pisa, Italy.

ORCID-Profile: Vincenzo Lionetti

Förderung

  • Fondazione Pisa
  • Scuola Superiore Sant'Anna
  • Università di Pisa

Zitieren

APA

Furini, G., De Carli, A., Fonnesu, R., Spezia, P. G., Scebba, F., Pistello, M., Lai, M., & Lionetti, V. (2023). Gene silencing of endothelial von Willebrand factor reduces the susceptibility of human endothelial cells to SARS‐CoV ‐2 infection. The FEBS Journal. https://doi.org/10.1111/febs.16808

Vancouver

Furini G, De Carli A, Fonnesu R, Spezia PG, Scebba F, Pistello M, et al. Gene silencing of endothelial von Willebrand factor reduces the susceptibility of human endothelial cells to SARS‐CoV ‐2 infection. The FEBS Journal. 2023. doi:10.1111/febs.16808

BibTeX
@article{Furini2023,
  author = {Furini, Giulia and De Carli, Alessandro and Fonnesu, Rossella and Spezia, Pietro Giorgio and Scebba, Francesca and Pistello, Mauro and Lai, Michele and Lionetti, Vincenzo},
  title = {Gene silencing of endothelial von Willebrand factor reduces the susceptibility of human endothelial cells to SARS‐CoV ‐2 infection},
  journal = {The FEBS Journal},
  year = {2023},
  doi = {10.1111/febs.16808}
}
Kostenlos starten →